查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623519

免标定检测的全球市场规模:各技术，各类产品·服务，各终端用户，各地区，范围及预测

Global Label-Free Detection Market Size By Technology (Surface Plasmon Resonance, Bio-layer Interferometry), By Product & Service (Biosensor Chips, Microplates), By End User (Pharmaceutical & Biotechnology Companies), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

无标记侦测的市场规模及预测

2023 年无标籤检测市场规模价值 20.9 亿美元，预计到 2030 年将达到 56.2 亿美元，2024 年至 2030 年的复合年增长率为 14.1%。该市场的成长得益于先进技术产品的引进、透过产学研合作不断增加的药物研发项目以及无标记技术灵敏度的不断提高。本研究报告对全球无标籤检测市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义无标记侦测的全球市场

一种被称为 "无标籤检测系统" 的整合系统用于研究生物分子交互作用，而不会减少标籤或自发性萤光效应。这些技术为发现新药提供了一种快速、即时的方法。采用无标籤检测方法进行生化和基于细胞的测试。无标记检测方法正被用于检测生物分子及其相互作用。对于生物技术和製药领域来说，这种方法是一种令人难以置信的研究和开发工具。由于製药公司和学术机构之间的合作增加以及药物研发计划的增加，预计市场将蓬勃发展。

无标记检测的全球市场概况

製药和生物技术领域日益增多的研发活动正在推动全球无标籤检测市场的发展。製药活动的外包和学术机构研发活动的激增促使对无标记检测技术的需求强劲。这些技术非常受欢迎，因为它们可以有效地管理多种讯号通路的复杂性。此外，无标记检测技术消除了自发性萤光和空间干扰的使用，从而促进了其应用。

政府和私人组织联合举办研讨会，以提高最终用户对使用无标籤检测技术的好处的认识，并有望确保市场的成长。除当前情况外，各企业不断努力开发尖端无标记检测技术也有望促进市场的成长。然而，无标记检测所需设备的高成本预计会限制该市场的成长。此外，最终用户缺乏专业知识以及对无标记检测技术的各种优势的认识较低也可能成为市场扩张的障碍。

目录

第1章 免标定检测的全球市场:简介

  • 市场概要
  • 调查范围
  • 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源一览

第4章 免标定检测的全球市场展望

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力分析
  • 价值链分析
  • 法律规范

第5章 免标定检测的全球市场:各技术

  • 概要
  • 表面等离子体共振
  • 生物层干涉测量法
  • 等温滴定量热法
  • 差示扫描量热法
  • 其他 Lfd 技术

第6章 免标定检测的全球市场:各类产品·服务

  • 概要
  • 设备
  • 消耗品
    • 生物感应器晶片
    • 微孔盘

第7章 免标定检测的全球市场:各终端用户

  • 概要
  • 製药·生物科技企业
  • 学术·研究机关
  • 受託研究机构
  • 其他的终端用户

第8章 免标定检测的全球市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 南美
    • 巴西
    • 阿根廷
  • 全球其他地区

第9章 免标定检测的全球市场:竞争情形

  • 概要
  • 企业市场占有率
  • 业者情势
  • 主要的发展策略

第10章 企业简介

  • General Electric
  • Danaher Corporation
  • Perkinelmer
  • Ametek
  • F. Hoffman-La Roche AG
  • Malvern Panalytical
  • TA Instruments
  • Corning Incorporated
  • Horiba
  • Shimadzu Corporation
  • Hitachi High-Technologies Corporation

第11章 附录

  • 相关调查
简介目录
Product Code: 24009

Label-Free Detection Market Size And Forecast

Label-Free Detection Market size was valued at USD 2.09 Billion in 2023 and is projected to reach USD 5.62 Billion by 2030 , growing at a CAGR of 14.1% from 2024 to 2030. Growth during this market is driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and thus the high sensitivity of label-free technologies. The Global Label-Free Detection Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Label-Free Detection Market Definition

The type of integrated systems known as "label-free detection systems" are used to examine biomolecular interactions without lowering the labels or auto-fluorescent effects. These technologies provide a quick and real-time method for finding novel drugs. Biochemical and cell-based tests are detected by label-free detection methods. For the purpose of detecting biomolecules and their interactions, the label-free detection approach is used. This approach has become a wonderful research and development tool for the biotech and pharmaceutical sectors. The market will develop as a result of partnerships between pharmaceutical corporations and academic institutions and the rise in drug discovery programs.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Label-Free Detection Market Overview

The growing research and development activities within the field of pharmaceuticals and biotechnology are driving the worldwide Label-Free Detection Market. A surge in outsourcing pharmaceutical activities and R&D activities by academic institutions are together responsible for the high demand for label-free detection techniques. These techniques are in high demand as they effectively manage the complexity of multiple signaling pathways. Moreover, label-free detection techniques eliminate the utilization of autofluorescent and spatial interference, boosting their adoption.

Joint efforts by governments and private organizations to organize seminars and increase awareness among end-users regarding the benefits of using label-free detection techniques are expected to ensure the growth of the market. In addition to the current state, continued efforts by businesses to create cutting-edge label-free detection techniques will contribute to the market's growth. On the other hand, the high cost of the equipment required for label-free detection would limit this market's growth. The end-users lack of expertise and poor levels of awareness about the various advantages of label-free detection techniques would also be a barrier to the market's expansion.

Global Label-Free Detection Market Segmentation Analysis

The Global Label-Free Detection Market is Segmented on the basis of Technology, Product & Service, End User, And Geography.

Label-Free Detection Market, By Technology

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Differential Scanning Calorimetry
  • Isothermal Titration Calorimetry
  • Other Label-free Detection Technologies

Based on Technology, the market is bifurcated into Surface Plasmon Resonance, Bio-layer Interferometry, Differential Scanning Calorimetry, Isothermal Titration Calorimetry, And Other Label-free Detection Technologies. The biosensor chips accounted for the most important share of the consumables segment mainly owing to the high specificity and skill to watch molecular interactions in real-time.

Label-Free Detection Market, By Product & Service

  • Biosensor Chips
  • Microplates
  • Reagents & Kits

Based on Product & Service, the market is bifurcated into Biosensor Chips, Microplates, And Reagents & Kits. The surface plasmon resonance segment accounted for the foremost important share, attributable to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.

Label-Free Detection Market, By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (Cros)
  • Others

Based on End User, the market is bifurcated into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (Cros), And Others. The pharmaceutical & biotechnology companies segment dominated the Label-Free Detection Market, owing to the extensive use of label-free detection technologies by pharmaceutical & biotechnology companies for studying biomolecular interactions in drug discovery.

Label-Free Detection Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Label-Free Detection Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America accounted for the most important share of the general market, followed by Europe. The availability of funds for research, increasing research activities in drug discovery and development, growth in pharmaceutical R&D spending, and the presence of key players are the major factors driving the North American market.

Key Players

  • The "Global Label-Free Detection Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Medtronic, Koninklijke Philips N.V., Ambu, Cognionics, Inc., Natus Medical Incorporated, 3M, CONMED Corporation, Rhythmlink International, LLC, Leonhard Lang GmbH (Acquired By DCC PLC.), Nihon Kohden Corporation, Compumedics Limited, G.Tec Medical Engineering GmbH, SOMNOmedics GmbH, NeuroSky, General Healthcare (Subsidiary of General Electric Company).

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LABEL-FREE DETECTION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL LABEL-FREE DETECTION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL LABEL-FREE DETECTION MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Surface Plasmon Resonance
  • 5.3 Bio-Layer Interferometry
  • 5.4 Isothermal Titration Calorimetry
  • 5.5 Differential Scanning Calorimetry
  • 5.6 Other Lfd Technologies

6 GLOBAL LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE

  • 6.1 Overview
  • 6.2 Instruments
  • 6.3 Consumables
    • 6.3.1 Biosensor Chips
    • 6.3.2 Microplates

7 GLOBAL LABEL-FREE DETECTION MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Pharmaceutical & Biotechnology Companies
  • 7.3 Academic & Research Institutes
  • 7.4 Contract Research Organizations
  • 7.5 Other End Users

8 GLOBAL LABEL-FREE DETECTION MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
  • 8.6 Rest of the World

9 GLOBAL LABEL-FREE DETECTION MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Share
  • 9.3 Vendor Landscape
  • 9.4 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 General Electric
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Danaher Corporation
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Perkinelmer
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Ametek
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 F. Hoffman-La Roche AG
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Malvern Panalytical
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 TA Instruments
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Corning Incorporated
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Horiba
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Shimadzu Corporation
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments
  • 10.11 Hitachi High-Technologies Corporation
    • 10.11.1 Overview
    • 10.11.2 Financial Performance
    • 10.11.3 Product Outlook
    • 10.11.4 Key Developments

11 Appendix

  • 11.1 Related Research